Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus

Author:  ["Susana Llanos","Paula A. Clark","Janice Rowe","Gordon Peters"]

Publication:  Nature Cell Biology

CITE.CC academic search helps you expand the influence of your papers.

Tags:  general   CellBiology   CancerResearch   DevelopmentalBiology   StemCells   Biological

Abstract

The alternative product of the human INK4a/ARF locus, p14ARF, has the potential to act as a tumour suppressor by binding to and inhibiting the p53 antagonist MDM2. Current models propose that ARF function depends on its ability to sequester MDM2 in the nucleolus. Here we describe situations in which stabilization of MDM2 and p53 occur without relocalization of endogenous MDM2 from the nucleoplasm. Conversely, forms of ARF that do not accumulate in the nucleolus retain the capacity to stabilize MDM2 and p53. We therefore propose that nucleolar localization is not essential for ARF function but may enhance the availability of ARF to inhibit MDM2.

Cite this article

Llanos, S., Clark, P., Rowe, J. et al. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat Cell Biol 3, 445–452 (2001). https://doi.org/10.1038/35074506

View full text

>> Full Text:   Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus

ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1

Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM